Application of melatonin composition in preparation of weight-reducing and lipid-lowering drug
A technology of melatonin and composition, applied in the application field of melatonin composition in the preparation of weight loss and lipid-lowering drugs, to achieve the effect of inhibiting the level of quinated protein, reducing body weight and abdominal fat weight, and reducing weight gain
Inactive Publication Date: 2020-10-30
上海百山生物技术有限公司
View PDF6 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
At present, there is no report on the application of EGCG combined with melatonin in the preparation of weight-loss and lipid-lowering drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1~6
[0030] Embodiment 1~6, a kind of melatonin composition
[0031] Melatonin composition formula, as shown in table 1:
[0032] group EGCG melatonin Stachyose Example 1 3.0mg / mL 0.2mg / mL 0.16mg / mL Example 2 3.5mg / mL 0.3mg / mL 0.45mg / mL Example 3 4.0mg / mL 0.5mg / mL 0.5mg / mL Example 4 4.5mg / mL 0.6mg / mL 1.2mg / mL Example 5 3.5mg / mL 0.4mg / mL 0.6mg / mL Example 6 3.5mg / mL 0.4mg / mL /
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention relates to the technical field of weight reduction and lipid reduction, in particular to an application of a melatonin composition in preparation of a weight-reducing and lipid-loweringdrug, the melatonin composition comprises melatonin and EGCG, and the mass ratio of the melatonin to the EGCG is (2-6): (30-45). According to the invention, the melatonin is combined with the EGCG foruse for the first time; the melatonin composition can reduce the body weight and abdominal fat weight of a mouse suffering from type 2 diabetes; the expression of fatty acid synthetase protein in abdominal fat of mice with type 2 diabetes mellitus and the expression of fatty acid synthetase protein in livers can be obviously inhibited; the melatonin composition can achieve the effects of reducingweight gain or losing weight and lowering lipid by inhibiting fat synthesis and reducing fat accumulation, stachyose is accidentally added, the quinonylation protein level can be remarkably inhibited, and the activity of EGCG can be improved.
Description
technical field [0001] The invention relates to the technical field of weight loss and lipid reduction, in particular to the application of a melatonin composition in the preparation of weight loss and lipid lowering drugs. Background technique [0002] Overnutrition and a long-term static lifestyle lead to overweight, obesity, and even type 2 diabetes. According to surveys by WHO and related agencies, as of 2014, the number of obese people in the world has exceeded 1.5 billion, and type 2 diabetes patients have exceeded 420 million; and it is predicted that by 2035, the number of global diabetic patients will exceed 600 million. Diabetes is a major global health problem. Except for HIV / AIDS, diabetes is the primary disease that reduces global health-adjusted life expectancy (HALE0). For a long time, reducing fat accumulation and thus controlling weight gain has been an effective means of preventing obesity and type 2 diabetes. [0003] Melatonin is secreted by the pineal ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
IPC IPC(8): A61K31/4045A61K31/353A61K31/702A61P3/04A61P3/10
CPCA61K31/353A61K31/4045A61K31/702A61P3/04A61P3/10A61K2300/00
Inventor 赵广山
Owner 上海百山生物技术有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap